Top

Published in:

Open Access 01-12-2020 | Parkinson's Disease | Correction

Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

Authors: Heinz Reichmann, Andrew Lees, José-Francisco Rocha, Diogo Magalhães, Patrício Soares-da-Silva, the OPTIPARK investigators

Excerpt

Correction to: Transl Neurodegener (2020) 9:9 …

Reichmann H, Lees A, Rocha JF, Magalhães D, Soares-da-Silva P, OPTIPARK investigators. Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study. Transl Neurodegener. 2020;9:9. https://doi.org/10.1186/s40035-020-00187-1.CrossRefPubMedPubMedCentral

Title: Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Authors: Heinz Reichmann
Andrew Lees
José-Francisco Rocha
Diogo Magalhães
Patrício Soares-da-Silva
the OPTIPARK investigators
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Parkinson's Disease
Levodopa
Opicapone
Published in: Translational Neurodegeneration / Issue 1/2020
Electronic ISSN: 2047-9158
DOI: https://doi.org/10.1186/s40035-020-00193-3